440 related articles for article (PubMed ID: 18924448)
21. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome.
Barbara G; Zecchi L; Barbaro R; Cremon C; Bellacosa L; Marcellini M; De Giorgio R; Corinaldesi R; Stanghellini V
J Clin Gastroenterol; 2012 Oct; 46 Suppl():S52-5. PubMed ID: 22955358
[TBL] [Abstract][Full Text] [Related]
22. Proteinase-activated receptors-1 and 2 induce electrogenic Cl- secretion in the mouse cecum by distinct mechanisms.
Ikehara O; Hayashi H; Watanabe Y; Yamamoto H; Mochizuki T; Hoshino M; Suzuki Y
Am J Physiol Gastrointest Liver Physiol; 2010 Jul; 299(1):G115-25. PubMed ID: 20413722
[TBL] [Abstract][Full Text] [Related]
23. Evidence that protease-activated receptor-2 mediates trypsin-induced reversal of stellation in cultured rat astrocytes.
Park GH; Ryu JR; Shin CY; Choi MS; Han BH; Kim WK; Kim HC; Ko KH
Neurosci Res; 2006 Jan; 54(1):15-23. PubMed ID: 16256233
[TBL] [Abstract][Full Text] [Related]
24. The role of protease activation of inflammation in allergic respiratory diseases.
Reed CE; Kita H
J Allergy Clin Immunol; 2004 Nov; 114(5):997-1008; quiz 1009. PubMed ID: 15536399
[TBL] [Abstract][Full Text] [Related]
25. Mesotrypsin, a brain trypsin, activates selectively proteinase-activated receptor-1, but not proteinase-activated receptor-2, in rat astrocytes.
Wang Y; Luo W; Wartmann T; Halangk W; Sahin-Tóth M; Reiser G
J Neurochem; 2006 Nov; 99(3):759-69. PubMed ID: 16903872
[TBL] [Abstract][Full Text] [Related]
26. Mesalazine (5-aminosalicylic acid) alters faecal bacterial profiles, but not mucosal proteolytic activity in diarrhoea-predominant irritable bowel syndrome.
Andrews CN; Griffiths TA; Kaufman J; Vergnolle N; Surette MG; Rioux KP
Aliment Pharmacol Ther; 2011 Aug; 34(3):374-83. PubMed ID: 21671966
[TBL] [Abstract][Full Text] [Related]
27. Fully human antibodies against the Protease-Activated Receptor-2 (PAR-2) with anti-inflammatory activity.
Giblin P; Boxhammer R; Desai S; Kroe-Barrett R; Hansen G; Ksiazek J; Panzenbeck M; Ralph K; Schwartz R; Zimmitti C; Pracht C; Miller S; Magram J; Litzenburger T
Hum Antibodies; 2011; 20(3-4):83-94. PubMed ID: 22129678
[TBL] [Abstract][Full Text] [Related]
28. Protease activated receptors in cardiovascular function and disease.
Barnes JA; Singh S; Gomes AV
Mol Cell Biochem; 2004 Aug; 263(1-2):227-39. PubMed ID: 15524183
[TBL] [Abstract][Full Text] [Related]
29. Luminal cysteine-proteases degrade colonic tight junction structure and are responsible for abdominal pain in constipation-predominant IBS.
Annaházi A; Ferrier L; Bézirard V; Lévêque M; Eutamène H; Ait-Belgnaoui A; Coëffier M; Ducrotté P; Róka R; Inczefi O; Gecse K; Rosztóczy A; Molnár T; Ringel-Kulka T; Ringel Y; Piche T; Theodorou V; Wittmann T; Bueno L
Am J Gastroenterol; 2013 Aug; 108(8):1322-31. PubMed ID: 23711626
[TBL] [Abstract][Full Text] [Related]
30. SERT and TPH-1 mRNA expression are reduced in irritable bowel syndrome patients regardless of visceral sensitivity state in large intestine.
Kerckhoffs AP; ter Linde JJ; Akkermans LM; Samsom M
Am J Physiol Gastrointest Liver Physiol; 2012 May; 302(9):G1053-60. PubMed ID: 22323131
[TBL] [Abstract][Full Text] [Related]
31. A protease activated receptor-2 (PAR-2) activating peptide, tc-LIGRLO-NH2, induces protease release from mast cells: role in TNF degradation.
Alshurafa HN; Stenton GR; Wallace JL; Hollenberg MD; Befus AD; Vliagoftis H
BMC Pharmacol; 2004 Jul; 4():12. PubMed ID: 15265236
[TBL] [Abstract][Full Text] [Related]
32. Alterations in serotonin, transient receptor potential channels and protease-activated receptors in rats with irritable bowel syndrome attenuated by Shugan decoction.
Shi HL; Liu CH; Ding LL; Zheng Y; Fei XY; Lu L; Zhou XM; Yuan JY; Xie JQ
World J Gastroenterol; 2015 Apr; 21(16):4852-63. PubMed ID: 25944998
[TBL] [Abstract][Full Text] [Related]
33. Intestinal type 2 proteinase-activated receptors: expression in opioid-sensitive secretomotor neural circuits that mediate epithelial ion transport.
Green BT; Bunnett NW; Kulkarni-Narla A; Steinhoff M; Brown DR
J Pharmacol Exp Ther; 2000 Oct; 295(1):410-6. PubMed ID: 10992008
[TBL] [Abstract][Full Text] [Related]
34. [Role of serotonin in the pathophysiology of the irritable bowel syndrome].
Moskwa A; Boznańska P
Wiad Lek; 2007; 60(7-8):371-6. PubMed ID: 18175558
[TBL] [Abstract][Full Text] [Related]
35. Proteinase-activated receptors.
Macfarlane SR; Seatter MJ; Kanke T; Hunter GD; Plevin R
Pharmacol Rev; 2001 Jun; 53(2):245-82. PubMed ID: 11356985
[TBL] [Abstract][Full Text] [Related]
36. Protease-activated receptors: protease signaling in the gastrointestinal tract.
Amadesi S; Bunnett N
Curr Opin Pharmacol; 2004 Dec; 4(6):551-6. PubMed ID: 15525542
[TBL] [Abstract][Full Text] [Related]
37. Hepta and octapeptide agonists of protease-activated receptor 2.
Devlin MG; Pfeiffer B; Flanagan B; Beyer RL; Cocks TM; Fairlie DP
J Pept Sci; 2007 Dec; 13(12):856-61. PubMed ID: 17890655
[TBL] [Abstract][Full Text] [Related]
38. Alterations of sensori-motor functions of the digestive tract in the pathophysiology of irritable bowel syndrome.
Delvaux M
Best Pract Res Clin Gastroenterol; 2004 Aug; 18(4):747-71. PubMed ID: 15324712
[TBL] [Abstract][Full Text] [Related]
39. A new soy germ fermented ingredient displays estrogenic and protease inhibitor activities able to prevent irritable bowel syndrome-like symptoms in stressed female rats.
Moussa L; Bézirard V; Salvador-Cartier C; Bacquié V; Houdeau E; Théodorou V
Clin Nutr; 2013 Feb; 32(1):51-8. PubMed ID: 22727545
[TBL] [Abstract][Full Text] [Related]
40. A novel therapeutic target in various lung diseases: airway proteases and protease-activated receptors.
Sokolova E; Reiser G
Pharmacol Ther; 2007 Jul; 115(1):70-83. PubMed ID: 17532472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
